Internal Medicine, Addiction Medicine · Worcester, MA
NPI
1164409231
Since 2005
Specialty
Internal Medicine, Addiction Medicine
Code 207RA0401X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
107 Lincoln St
Worcester, MA, 01605
Phone (508) 799-9000
Groups this clinician bills Medicare through
Medicare paid, 2024
$98K
1,400 services
Medicare patients, 2024
253
Average age 57
Drug cost, 2024
$63K
957 prescriptions
Company payments, 2025
$418
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wojciech Poluha was code 99232 (hospital e&m - subsequent), 804 times for 187 patients. In total Wojciech Poluha billed 1,400 services in 7 codes, and Medicare paid $98K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-12-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 804 | 187 | $61.54 | $49K |
| 99233 Hospital E&M - Subsequent | Facility | 255 | 101 | $93.19 | $24K |
| 99238 Hospital Discharge Management | Facility | 191 | 168 | $63.60 | $12K |
| 99222 Hospital E&M - Initial | Facility | 60 | 59 | $99.94 | $5,996 |
| 99223 Hospital E&M - Initial | Facility | 29 | 27 | $132.23 | $3,835 |
By year: 2022 $110K for 1,903 services; 2023 $127K for 2,026 services; 2024 $98K for 1,400 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 51 | 14 | $12.44 | $635 |
Medicare prescription drug claims, 2024
In 2024, the drug Wojciech Poluha prescribed most often to Medicare patients was Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl), with 176 prescriptions and refills. In total Wojciech Poluha wrote 957 Medicare prescriptions that cost $63K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 176 | 176 | 20 | $22K |
| Clonidine Hcl Generic | 81 | 95 | 63 | $562 |
| Acamprosate Calcium Generic | 69 | 74 | 60 | $4,735 |
| Trazodone Hcl Generic | 35 | 38 | 28 | $331 |
| Hydroxyzine Hcl Generic | 34 | 34 | 29 | $675 |
| Ibuprofen Generic | 30 | 30 | Under 11 | $118 |
| Quetiapine Fumarate Generic | 27 | 27 | 18 | $398 |
| Cyclobenzaprine Hcl Generic | 25 | 25 | 24 | $250 |
| Hydroxyzine Pamoate Generic | 23 | 23 | 20 | $309 |
| Doxepin Hcl Generic | 21 | 29 | 14 | $494 |
| Diclofenac Sodium Generic | 21 | 21 | 15 | $326 |
| Baclofen Generic | 17 | 17 | 16 | $249 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 16 | 18 | 13 | $646 |
| Suboxone Buprenorphine Hcl/Naloxone Hcl | 15 | 15 | Under 11 | $10K |
| Omeprazole Generic | 13 | 13 | Under 11 | $310 |
Brand drugs: - claims; generic drugs: 892 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wojciech Poluha $418 ($418 in general payments such as food, travel and fees) from 6 companies. The largest payer was Indivior Inc. with $159.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.